Overview


Infusion pumps are used to inject fluids, medication, or nutrients into the patient's circulation system. Although it is most commonly used intravenously (subcutaneous, arterial, and epidural), infusions can be made occasionally. Infusion pumps are able to administer fluids in ways that are unpractical or unreliable for nursing staff. They can give injections at a rate of 0.1 mL an hour (too small to be a drip), every-minute injections, or injections with multiple boluses as requested by patients, up to a maximum of 24 hours (e.g. In patient-controlled analgesia, or fluids whose volume varies according to the day.
They can also inject controlled amounts of fluids under the skin (just beneath the surface of the central nervous system) or epidurally (just below the surface of the central nervous system). This is a popular local spinal anesthesia for childbirth. End-stage heart failure is when the heart condition is considered advanced. Heart failure is a condition in which the heart has a reduced ability to pump blood and maintain normal bodily functions. End-stage heart failure is treated with heart transplantation. There are not enough donor hearts available to fulfill the demand. Many patients are not eligible due to their age or other medical conditions. End-stage heart failure can be treated with ventricular assist devices (VAD). The ventricular assist device (VAD) is a mechanical pump that supports the heart and blood flow. It can take on the workload of either the right ventricle, left ventricle, or both ventricles. This allows the heart to pump oxygenated blood into the rest of the body. Ventricular arrhythmias, also known as vas, are potentially fatal conditions that can lead to sudden cardiac death (SCD). The increased use of implantable cardiac devices (ICD) has led to a shift in VA management towards reducing morbidity. AADs (anti-arrhythmic drugs) is an important adjunct therapy for the treatment of recurrent vasculitides. Amiodarone is the current, most researched, and recommended pharmacologic treatment for VAs secondary to structural cardiac disease. Beta-blockers are an important adjunct, and they are often overlooked. They provide strong evidence support. AADs are able to offer targeted therapies for patients with specific syndromes and structurally normal hearts.

To evaluate the effectiveness of newer therapies and to compare them with existing AADs, further clinical trials are needed. Ventricular infusion pumps are seeing rapid growth due to the increasing incidence of chronic diseases and the rise in elderly populations. There is also a growing demand for ambulatory pumps. Also, there has been an increase in the volume of surgeries performed around the globe. The growing prevalence of chronic diseases like cancer, as well as the increased adoption of infusion pumps, is driving the global ventricular market for infusion pumps. The market offers many growth opportunities due to the increasing use of specialty infusion systems as well as the growing demand for infusion pumps in developing markets. A rapid advance in technology in healthcare has also led to a greater awareness of health. The use of ventricular pumps is expected to increase. The market's growth is due to technological advancements, safety features, and the variety of equipment sizes. FutureWise Market Research has instantiated a report that provides an intricate analysis of Ventricular Infusion Pump Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Ventricular Infusion Pump Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott
  • Bioventrix Inc
  • Xeltis AG
  • Neochord Inc
  • CryoLife Inc
  • Edwards Lifesciences Corp.
  • CardioKinetics Inc
  • On-X Life technologies Inc
  • valtec
  • Medtronic

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Application

  • Percutaneous ventricular Restoration
  • Surgical ventricular Restoration

By End-user

  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgical centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Ventricular Infusion Pump Market By Application, By End-user and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Ventricular Infusion Pump Market Variables, Trends and Scope
    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Ventricular Infusion Pump Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Ventricular Infusion Pump Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Application Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Application Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Ventricular Infusion Pump Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Percutaneous ventricular Restoration
        2. Surgical ventricular Restoration

  • 8.   Ventricular Infusion Pump Market, By End-user Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Specialty Clinics
        2. Hospitals
        3. Ambulatory Surgical centers

  • 9.   North America Ventricular Infusion Pump Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Ventricular Infusion Pump Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Ventricular Infusion Pump Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Ventricular Infusion Pump Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bioventrix Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Xeltis AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Neochord Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. CryoLife Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Edwards Lifesciences Corp.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. CardioKinetics Inc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. On-X Life technologies Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. valtec
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Medtronic
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients